Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    



Vanderbilt Researchers Identify Protein's Possible Role in Chemotherapy Resistance


 
David Cortez, Ph.D.

Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.

The protein, RADX, is a DNA-binding protein. It regulates the activity of an enzyme called RAD51, which helps repair tumor-promoting DNA breaks and ensure an accurate copy of the DNA is made during cell division. RAD51, in turn, is gathered up and transported to the sites of DNA damage and DNA replication by the BRCA2 protein.

Mutations in the BRCA2 gene disrupt the DNA repair and replication functions of the BRCA2/RAD51 pathway, increasing the risk of cancers of the breast, ovaries, prostate and pancreas as well as melanoma.

Since BRCA2 mutations also reduce the ability of tumor cells to repair broken DNA, these cells are sensitive to DNA-damaging anti-cancer drugs like cisplatin and newly approved DNA repair inhibitors like Olaparib. If the cells acquire secondary mutations that restore normal BRCA2 function, however, they can become resistant to the drugs.

This is the case with ovarian cancer. Within six months one quarter of ovarian tumors will become resistant to cisplatin. Only a third of patients survive beyond five years, making ovarian cancer the fifth-leading cause of cancer death among women in the United States.

RADX, the protein discovered by the Vanderbilt scientists, may be a key to understanding and overcoming this resistance.

In a paper published in the journal Molecular Cell, David Cortez, Ph.D., and colleagues describe how RADX regulates the activity of RAD51 in a way that promotes genome stability and modulates drug sensitivity.

Much remains to be learned. But if, as suspected, RADX determines how tumors respond to therapy, it could be a target for efforts to overcome resistance, the researchers concluded.

The paper's first authors were Huzefa Dungrawala, Ph.D., a postdoctoral fellow in Cortez's lab, and graduate student Kamakoti Bhat. Cortez is Ingram Professor of Cancer Research and professor of Biochemistry and co-leader of the Genome Maintenance Program in the Vanderbilt-Ingram Cancer Center.

The research was supported in part by National Institutes of Health grants GM116616, CA092584, CA212435 and GM118089.

 
Share:

Related Articles:


Recent Articles

Senate HELP Committee Hearing on Gene Editing Technology

On Nov. 14, the Senate health committee held a hearing on the gene editing method CRISPR to learn more about the technology from expert witnesses, which included Dr. Matthew Porteus, associate professor of Pediatrics at Stanford University; Katrine Bosley, CEO and president of Editas Medicine; and Dr. Jeffrey Kahn, director of the Johns Hopkins Berman Institute of Bioethics at Johns Hopkins School of Public Health.

Read More

Nashville Health Care Council Hosts Panel Discussion on Pharma/Provider Collaborations in Health Care

On Nov. 13, the Nashville Health Care Council hosted a panel discussion on collaborations between the pharmaceutical and healthcare provider sectors and how those collaborations can drive change in healthcare.

Read More

Tennessee Health Care Hall of Fame Class of 2017

Six healthcare luminaries were recently inducted into the Tennessee Health Care Hall of Fame.

Read More

NMGMA 10 Minute Takeaway

Nashville Medical News recently had the opportunity to chat with new NMGMA president Joy Testa.

Read More

Tennessee Joins Medical Licensing Compact

A new Tennessee law will make it easier for area physicians to practice across state lines beginning in 2019 as part of the Interstate Medical Licensure Compact.

Read More

A Plan to Address COPD

COPD is the third leading cause of death in America, yet it lags behind many other conditions in terms of research dollars and coordinated federal response ... but that seems to be changing.

Read More

Surgical Innovations

Two new procedures recently made their debut in Middle Tennessee offering new treatment options for coronary bifurcation lesions and lumbar fusion.

Read More

Don't fear the FBAR

If you are a taxpayer with offshore financial accounts, you could be in trouble with the IRS and not even know it.

Read More

HoneyCo Homes: Using Smart Technology to Help Seniors Age in Place

A Nashville startup is using technology to help seniors age in place while providing peace of mind to loved ones and actionable data to caregivers.

Read More

A Better Continuum Means Better Care

As the U.S. population ages, new partnerships along the continuum of care are necessary to achieve optimal outcomes for patients.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: